ACADIA PHARMACEUTICALS INC
For the period ended Dec 31, 2025. Filed Feb 26, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 26, 2026
ACAD$18.28+10.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Comprehensive Income (Loss)
| Years Ended December 31, | |||
|---|---|---|---|
| 2025 | 2024 | 2023 | |
| Net income (loss) | $391,000 | $226,451 | $(61,286) |
| Other comprehensive income (loss): | |||
| Unrealized gain on investment securities | 1,127 | 362 | 1,017 |
| Foreign currency translation adjustments | 26 | (94) | (18) |
| Comprehensive income (loss) | $392,153 | $226,719 | $(60,287) |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.